±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 172  |  »Ø¸´: 1
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

wangshixiaowsx

½ð³æ (СÓÐÃûÆø)

[½»Á÷] ººÒëÓ¢

¿ª»·ºËÜÕÀ࿹²¡¶¾Ò©ÎïµÄÑо¿¸Å¿ö
ÕªÒª£º¿ª»·ºËÜÕÀ࿹²¡¶¾Ò©Îï¾ßÓеͶ¾¡¢µÍÄÍÊÜÐԺ͹ãÆ×¿¹DNA²¡¶¾»îÐÔ£¬Æäǰҩ¸üÊÇÌá¸ßÁËÒ©ÎïµÄ¿Ú·þÉúÎïÀûÓöȡ£±¾ÎÄ×ÛÊöÁ˼¸ÖÖ³£¼û¿ª»·ºËÜÕÀàÒ©Îï¼°Æäǰҩ½üÄêµÄÑо¿½øÕ¹£¬ÔÚ´Ë»ù´¡ÉÏÕ¹ÍûÁË¿¹²¡¶¾Ò©ÎïµÄÑо¿·½Ïò¡£

[ Last edited by wangshixiaowsx on 2010-1-24 at 20:06 ]
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

allain

ľ³æ (ÖøÃûдÊÖ)

¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
wangshixiaowsx(½ð±Ò+6): 1-24 22:17
A general overview of study of open-loop nucleoside antiviral drugs
Abstract: Open-loop nucleoside antiviral drugs have low toxicity, low tolerance and wide-spectrum of anti-DNA virus activity, and furthermore the prodrugs have improved the oral bioavailability. In this paper, the research process of  several common kinds of  open-loop nucleoside drugs and the prodrugs in recent years was generalized, and on this basis, the research direction of antiviral drugs was forcasted.
2Â¥2010-01-24 21:44:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ wangshixiaowsx µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 312Çóµ÷¼Á +3 Say Never 2026-04-04 3/150 2026-04-05 11:19 by guoweigw
[¿¼ÑÐ] µ÷¼ÁÇóÖú +10 Ïë»»ÊÖ»ú²»Ïë½âÊ 2026-04-02 13/650 2026-04-05 09:41 by sam3303
[¿¼ÑÐ] 0832ʳƷ¿ÆÑ§Ó빤³Ìѧ˶282µ÷¼Á +5 ÓãÔÚË®ÖÐÓÎa 2026-04-02 8/400 2026-04-05 09:06 by llyytt
[¿¼ÑÐ] 311·Ö 22408 Çóµ÷¼Á +3 bing_bot 2026-04-03 3/150 2026-04-05 00:43 by chongya
[¿¼ÑÐ] Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319 +21 678lucky 2026-03-31 26/1300 2026-04-04 16:22 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á +11 lyz0427 2026-04-03 11/550 2026-04-04 15:31 by dongzh2009
[¿¼ÑÐ] Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á +9 hanamiko 2026-03-30 9/450 2026-04-04 11:04 by Öí»á·É
[¿¼ÑÐ] 297Çóµ÷¼Á +11 ljy20040718£¡ 2026-04-03 13/650 2026-04-04 09:23 by À´¿´Á÷ÐÇÓê10
[¿¼ÑÐ] 350Ò»Ö¾Ô¸±±¾©º½¿Õº½Ìì´óѧ08500²ÄÁÏ¿ÆÑ§Ó빤³ÌÇóµ÷¼Á +5 kjnasfss 2026-04-03 5/250 2026-04-03 22:29 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] ÉúÎïѧÇóµ÷¼Á +3 15064154688 2026-04-03 3/150 2026-04-03 10:28 by macy2011
[¿¼ÑÐ] 372·Ö²ÄÁÏÓ뻯¹¤£¨085600£©Ò»Ö¾Ô¸ºþÄÏ´óѧÇóµ÷¼Á +5 À¶¼ãƬ 2026-04-02 6/300 2026-04-02 21:37 by dongzh2009
[¿¼ÑÐ] 08¹¤¿ÆÇóµ÷¼Á290·Ö +5 1314Åõ»¨ 2026-04-02 8/400 2026-04-02 13:16 by ÇÇßÕßÕßÕ
[¿¼ÑÐ] 314Çóµ÷¼Á +11 1xiaojun23 2026-03-31 12/600 2026-04-02 12:31 by 1xiaojun23
[¿¼ÑÐ] ²ÄÁϹ¤³Ì322·Ö +8 ¹þ¹þ¹þºðºðºð¹þ 2026-04-01 8/400 2026-04-02 11:53 by 3041
[¿¼ÑÐ] 279Çóµ÷¼Á +7 Īxiao 2026-04-01 7/350 2026-04-01 22:05 by ¿Í¶ûÃÀµÂ
[¿¼ÑÐ] 311Çóµ÷¼Á +10 ÀîÜÆÐÂ1 2026-03-31 10/500 2026-04-01 14:38 by chenqifeng666
[¿¼ÑÐ] ÍÁľ304Çóµ÷¼Á +5 ¶¥¼¶²Á²Á 2026-03-31 5/250 2026-04-01 08:15 by fdcxdystjk£¤
[¿¼ÑÐ] 289Çóµ÷¼Á +7 BrightLL 2026-03-29 7/350 2026-03-31 22:05 by 544594351
[¿¼ÑÐ] ¸£½¨Àí¹¤´óѧ²ÄÁÏѧԺÏȽøºÏ½ðÍŶÓÕÐÊÕ¿¼Ñе÷¼ÁѧÉú +3 ´ó»ª½ðÉ̶¼ 2026-03-30 4/200 2026-03-31 01:04 by ·½Ó¢¿¡602
[¿¼ÑÐ] Ò»Ö¾Ô¸»ªÖÐʦ·¶»¯Ñ§332·ÖÇóµ÷¼Á +3 Lyy930824@ 2026-03-29 3/150 2026-03-30 20:15 by DHUSHUAI
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û